| Product Code: ETC6736444 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
China continues to see a steady increase in its import shipments of antibodies, with top exporting countries such as the USA, Switzerland, and Spain leading the way in 2024. The Herfindahl-Hirschman Index (HHI) indicates a moderate concentration within the market, suggesting a competitive landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stands at a robust 8.88%, with a notable growth rate of 8.37% from 2023 to 2024. These figures highlight the growing demand for antibodies in China and the dynamic nature of the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Antibodies Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 China Antibodies Market - Industry Life Cycle |
3.4 China Antibodies Market - Porter's Five Forces |
3.5 China Antibodies Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 China Antibodies Market Revenues & Volume Share, By Antibodes Type, 2021 & 2031F |
3.7 China Antibodies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 China Antibodies Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 China Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 China Antibodies Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 China Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in research and development activities for antibody-based therapies |
4.2.2 Growing prevalence of chronic diseases driving the demand for targeted antibody treatments |
4.2.3 Advancements in biotechnology and genetic engineering leading to the development of novel antibodies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for antibody drug approval in China |
4.3.2 High costs associated with the development and production of antibodies |
4.3.3 Limited awareness and understanding of antibody therapies among healthcare professionals and patients in China |
5 China Antibodies Market Trends |
6 China Antibodies Market, By Types |
6.1 China Antibodies Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Antibodies Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 China Antibodies Market Revenues & Volume, By Primary, 2021- 2031F |
6.1.4 China Antibodies Market Revenues & Volume, By Secondary, 2021- 2031F |
6.2 China Antibodies Market, By Antibodes Type |
6.2.1 Overview and Analysis |
6.2.2 China Antibodies Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.2.3 China Antibodies Market Revenues & Volume, By Polyclonal Antibodies, 2021- 2031F |
6.3 China Antibodies Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 China Antibodies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.3.3 China Antibodies Market Revenues & Volume, By Immunofluorescence, 2021- 2031F |
6.3.4 China Antibodies Market Revenues & Volume, By Western Blotting, 2021- 2031F |
6.3.5 China Antibodies Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.6 China Antibodies Market Revenues & Volume, By Immunoprecipitation, 2021- 2031F |
6.3.7 China Antibodies Market Revenues & Volume, By ELISA, 2021- 2031F |
6.4 China Antibodies Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 China Antibodies Market Revenues & Volume, By Mouse, 2021- 2031F |
6.4.3 China Antibodies Market Revenues & Volume, By Rabbit, 2021- 2031F |
6.4.4 China Antibodies Market Revenues & Volume, By Goat, 2021- 2031F |
6.4.5 China Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Antibodies Market, By Application |
6.5.1 Overview and Analysis |
6.5.2 China Antibodies Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.5.3 China Antibodies Market Revenues & Volume, By Immunology, 2021- 2031F |
6.5.4 China Antibodies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.5.5 China Antibodies Market Revenues & Volume, By Stem Cells, 2021- 2031F |
6.5.6 China Antibodies Market Revenues & Volume, By Neurobiology, 2021- 2031F |
6.5.7 China Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Antibodies Market, By End use |
6.6.1 Overview and Analysis |
6.6.2 China Antibodies Market Revenues & Volume, By Academic & Research Institutes, 2021- 2031F |
6.6.3 China Antibodies Market Revenues & Volume, By Contract Research Organizations, 2021- 2031F |
6.6.4 China Antibodies Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
7 China Antibodies Market Import-Export Trade Statistics |
7.1 China Antibodies Market Export to Major Countries |
7.2 China Antibodies Market Imports from Major Countries |
8 China Antibodies Market Key Performance Indicators |
8.1 Number of new antibody drug approvals in China |
8.2 Investment trends in antibody research and development in the country |
8.3 Adoption rate of antibody-based therapies in Chinese healthcare facilities |
9 China Antibodies Market - Opportunity Assessment |
9.1 China Antibodies Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 China Antibodies Market Opportunity Assessment, By Antibodes Type, 2021 & 2031F |
9.3 China Antibodies Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 China Antibodies Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 China Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.6 China Antibodies Market Opportunity Assessment, By End use, 2021 & 2031F |
10 China Antibodies Market - Competitive Landscape |
10.1 China Antibodies Market Revenue Share, By Companies, 2024 |
10.2 China Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here